Key Events This Week
20 Jul: Week opens at Rs.2,068.00
21 Jul: New 52-week and all-time high reached (Rs.2,128.45 / Rs.2,121.00)
23 Jul: Technical momentum shifts to bullish despite 2.23% decline
24 Jul: Strong rebound closes week at Rs.2,114.10 (+4.28%)
Monday, 20 July 2026: Week Opens with Slight Decline
Corona Remedies Ltd started the week at Rs.2,042.35, down 1.24% from the previous Friday’s close of Rs.2,068.00. The stock traded on relatively low volume of 1,328 shares, while the Sensex remained flat, closing at 36,504.94 with a negligible 0.00% change. This cautious start reflected a subdued market mood ahead of the company’s significant price action later in the week.
Tuesday, 21 July 2026: New 52-Week and All-Time Highs Amid Strong Outperformance
On 21 July, Corona Remedies Ltd surged to a new 52-week high of Rs.2,128.45 and an all-time high of Rs.2,121.00, marking a pivotal moment in the stock’s trajectory. The stock closed at Rs.2,089.15, up 2.29% on the day, significantly outperforming the Sensex which gained a mere 0.04%. Intraday, the stock rose by over 4%, reflecting robust buying interest within the Pharmaceuticals & Biotechnology sector.
This rally was supported by the stock trading above all key moving averages (5, 20, 50, 100, and 200-day), signalling strong technical momentum. Despite a modest decline in the previous session, the stock’s year-to-date return of 47.37% and one-month gain of 10.55% underscored its resilience and appeal amid broader market volatility.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Wednesday, 22 July 2026: Sharp Decline Amid Market Weakness
The stock retraced sharply on 22 July, closing at Rs.2,042.60, down 2.23% from the previous day’s close. This decline occurred alongside a broader market sell-off, with the Sensex falling 0.88% to 36,196.43. The volume was notably thin at 380 shares, suggesting limited conviction behind the drop.
Despite the pullback, technical indicators remained constructive. The stock’s price stayed above critical moving averages, and Bollinger Bands on the weekly chart continued to signal a mildly bullish outlook. The decline appeared to be a short-term correction within an ongoing uptrend rather than a reversal.
Thursday, 23 July 2026: Technical Momentum Upgraded to Bullish Despite Price Drop
On 23 July, Corona Remedies Ltd closed at Rs.2,027.40, down 0.74% on heavy volume of 34,563 shares. Although the stock price declined, technical momentum shifted from mildly bullish to bullish, supported by positive signals from the Know Sure Thing (KST) oscillator and Dow Theory analysis on weekly and monthly charts.
The On-Balance Volume (OBV) indicator also turned bullish, suggesting accumulation despite the price dip. The Relative Strength Index (RSI) remained neutral, indicating room for further price movement without overbought conditions. This nuanced technical upgrade amid short-term volatility highlighted the stock’s underlying strength within the Pharmaceuticals & Biotechnology sector.
Friday, 24 July 2026: Strong Rebound Closes Week on a Positive Note
Corona Remedies Ltd rebounded sharply on the final trading day, closing at Rs.2,114.10, up 4.28% from Thursday’s close. This surge outpaced the Sensex’s 0.32% decline, underscoring the stock’s relative strength. The volume of 3,940 shares indicated renewed investor interest and confidence.
This strong finish capped a week of mixed price action but overall positive momentum, with the stock ending above its opening price for the week. The technical indicators’ bullish tilt and the stock’s ability to outperform the benchmark index despite market headwinds were key highlights.
Holding Corona Remedies Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Corona Remedies Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-20 | Rs.2,042.35 | -1.24% | 36,504.94 | -0.00% |
| 2026-07-21 | Rs.2,089.15 | +2.29% | 36,518.28 | +0.04% |
| 2026-07-22 | Rs.2,042.60 | -2.23% | 36,196.43 | -0.88% |
| 2026-07-23 | Rs.2,027.40 | -0.74% | 35,944.66 | -0.70% |
| 2026-07-24 | Rs.2,114.10 | +4.28% | 35,829.46 | -0.32% |
Key Takeaways from the Week
Positive Signals: Corona Remedies Ltd demonstrated resilience by outperforming the Sensex by over 4% during a week of broad market weakness. The stock’s new 52-week and all-time highs on 21 July reflected strong investor demand and technical strength. The upgrade in technical momentum to bullish on 23 July, supported by multiple indicators including KST, Dow Theory, and OBV, suggests a constructive medium-term outlook. The strong rebound on 24 July confirmed renewed buying interest and volume support.
Cautionary Notes: The stock experienced notable intraday and day-to-day volatility, with declines on 22 and 23 July indicating short-term profit-taking or market uncertainty. The Mojo Grade downgrade to Hold from Buy signals a tempered analyst stance, reflecting the need for cautious risk management given the stock’s small-cap status and premium valuation multiples. Neutral RSI and MACD readings suggest the stock may consolidate before any sustained directional move.
Conclusion: A Week of Mixed Signals but Overall Strength
Corona Remedies Ltd’s performance over the week ending 24 July 2026 was characterised by significant price milestones and evolving technical momentum. Despite intermittent pullbacks, the stock closed the week with a 2.23% gain, comfortably outperforming the Sensex’s 1.85% decline. The attainment of new highs and the shift to a bullish technical trend underscore the stock’s underlying strength within the Pharmaceuticals & Biotechnology sector.
While the Mojo Grade Hold rating advises prudence, the stock’s relative outperformance and positive technical indicators suggest it remains well-positioned for investors with a medium-term horizon. Monitoring volume trends and key technical signals will be essential to gauge the sustainability of this momentum amid ongoing market volatility.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
